BoxGroup

Overview

BoxGroup is a seed-stage venture firm based in New York City and San Francisco that spent its first decade investing only its partners’ own money, then scaled rapidly once it accepted outside capital — from $165 million in 2019 to $425 million in 2023 (TechCrunch; TechCrunch). Led by David Tisch, it is known for trying to be a founder’s “first yes”: the first believer before a company has traction to show (TechCrunch).

This profile covers the venture firm BoxGroup and follows it from its partner-funded decade through its three externally backed fund pairs, its signature early bets, and its investment in the trading-card platform Alt.

A decade of partners’ own money

BoxGroup’s early distinction was its funding source: until 2019 it had been internally backed, meaning the cash came from none other than its three partners — David Tisch, Adam Rothenberg and Nimi Katragadda (TechCrunch). It wrote smaller checks, usually between $250,000 and $500,000, for early-stage startups (TechCrunch). Unlike many venture firms it did not take board seats or “ownership” over the companies it backed, but participated in seed rounds across verticals including health, biotech and food alongside SaaS products, marketplaces and e-commerce (TechCrunch).

That patience produced early positions in companies that became household names. BoxGroup was the first firm to write Plaid a check, and the first investor in PillPack, which sold to Amazon for just under $1 billion in 2018 (TechCrunch). Its 2019 exits also included Flatiron Health, sold to Roche for $2.1 billion, and Harry’s, sold to Edgewell Personal Care for $1.37 billion (TechCrunch). By 2021 its portfolio of more than 300 investments included the earliest rounds of Ro, Plaid, Airtable, Workrise, Scopely, Bowery Farms, Ramp, Titan, Warby Parker, ClassPass, Guideline and Glossier (TechCrunch). Its habit of staying with companies showed in Ro, which BoxGroup pre-seeded and then funded in every round since, including a $500 million round at a $5 billion valuation, and in id.me, first backed in 2010 and described in 2021 as “an eleven-year overnight success” (TechCrunch).

The “first yes” philosophy was explicit. “If you’re starting a company and you’re going to raise money, that first yes is the hardest. And it’s the one that gives you the confidence, the excitement — to know that there’s somebody out there that’s going to believe in this and give you money for it,” Tisch told TechCrunch (TechCrunch). Partner Nimi Katragadda added that the firm backed founders sometimes more than once, even if an earlier company had not worked out, and was comfortable with “a lot of assumptions, more vision than traction, and raw product” (TechCrunch).

Three fund pairs, and Alt

In October 2019 BoxGroup raised its very first fund from limited partners — actually two funds, a seed fund and an Opportunity fund, each managing $82.5 million (TechCrunch). Limited partners included Willoughby Capital, TrueBridge and portfolio founders TJ Parker of PillPack, Jeff Raider of Harry’s and Nat Turner of Flatiron Health (TechCrunch). Tisch’s message was continuity: “we’re not changing,” he said, arguing that in an industry where everyone regularly changed strategy, staying true to collaborative seed checks mattered (TechCrunch). The external money would mainly let the firm better support its portfolio with follow-on investments (TechCrunch).

Fund pair	Year	Total
BoxGroup Four (seed + Opportunity)	2019	$165 million
BoxGroup Five + BoxGroup Strive	2021	$255 million
BoxGroup Six + BoxGroup Picks	2023	$425 million

Two years later the firm announced BoxGroup Five, its fifth early-stage fund, and BoxGroup Strive, its second opportunity fund, at $127.5 million each — $255 million total (TechCrunch). The early-stage fund would invest in about 40 to 50 new companies a year at $250,000 to $1 million each, with Tisch aiming to be “the second or third biggest check in a round” (TechCrunch). The team of six described itself as generalist, spanning consumer, enterprise, fintech, healthcare, marketplace, synthetic biology and climate (TechCrunch).

In December 2023, as early-stage venture investment slowed, BoxGroup quietly closed on $425 million across two new funds: BoxGroup Six, a pre-seed and seed-stage fund, and BoxGroup Picks, its third opportunity fund, at $212.5 million each (TechCrunch). The sixth early-stage fund was almost double the fifth, and Tisch called that growth “of note” in a difficult environment, crediting new institutional limited partners who joined that round (TechCrunch). The four partners had worked together for the better part of a decade, and with two new associates the firm numbered eight people (TechCrunch). Recent investments named at the time included Ramp, Warp, Hex, Solugen, Vial, Arcadia, Nourish, Coast, Turquoise Health and Backbone (TechCrunch). Tisch framed the moment as a return to normalcy after the frenzy of 2021 — “more like the 2018, 2019 market” — with artificial intelligence reigniting early-stage investing (TechCrunch).

BoxGroup’s own earliest-stage habit is visible in its Alt position: TechCrunch listed BoxGroup among Alt’s investors at its March 2021 launch, and Crunchbase News listed it among the Series A investors (TechCrunch; Crunchbase News).

What this profile does not claim

• No single founding year is asserted: directories give 2007 or 2009, while TechCrunch’s age statements imply roughly 2009–2010. The founding pair is likewise not asserted from a fully-read editorial source.
• A reported 2025 fundraise of $550 million is not claimed; it appears only in directory coverage.
• Current headcount, portfolio count and fund deployment pace are not stated.
• The firm’s investments in companies named here are early-round positions as reported; the profile does not claim current holdings or returns.